|Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning 1 H …|
T Seierstad, K Røe, B Sitter, J Halgunset, K Flatmark, AH Ree, DR Olsen, ...
Molecular Cancer 7 (1), 33, 2008
|Superparamagnetic magnetite nanoparticles for cancer theranostics|
A Kleinauskas, JK Kim, GH Choi, HT Kim, K Røe, P Juzenas
Reviews in Nanoscience and Nanotechnology 1 (4), 271-283, 2012
|Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal …|
T Seierstad, K Røe, DR Olsen
Radiotherapy and Oncology 85 (2), 187-194, 2007
|Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabine, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice|
T Seierstad, S Folkvord, K Røe, K Flatmark, A Skretting, DR Olsen
Neoplasia 9 (5), 392-400, 2007
|Inhibitory effects of oxaliplatin in experimental radiation treatment of colorectal carcinoma: does oxaliplatin improve 5-fluorouracil-dependent radiosensitivity?|
S Folkvord, K Flatmark, T Seierstad, K Røe, H Rasmussen, AH Ree
Radiotherapy and Oncology 86 (3), 428-434, 2008
|Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF (V600E) and BRAF wild-type metastatic malignant melanoma|
A Tahiri, K Røe, AH Ree, R de Wijn, K Risberg, C Busch, PE Lønning, ...
PLoS One 8 (8), e72692, 2013
|Preclinical dynamic 18F-FDG PET – tumor characterization and radiotherapy response assessment by kinetic compartment analysis|
K Røe, TB Aleksandersen, A Kristian, LB Nilsen, T Seierstad, H Qu, ...
Acta oncologica 49 (7), 914-921, 2010
|Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study|
K Røe, M Kakar, T Seierstad, AH Ree, DR Olsen
Radiation oncology 6 (1), 1-9, 2011
|Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer|
HB Ragnum, K Røe, R Holm, L Vlatkovic, JM Nesland, EK Aarnes, ...
International Journal of Radiation Oncology* Biology* Physics 87 (4), 753-760, 2013
|Personalized radiotherapy: concepts, biomarkers and trial design|
AH Ree, KR Redalen
The British journal of radiology 88 (1051), 20150009, 2015
|Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts|
E Hagtvet, K Røe, DR Olsen
Radiation Oncology 6 (1), 135, 2011
|MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer|
T Seierstad, KH Hole, KK Grøholt, S Dueland, AH Ree, K Flatmark, ...
The British journal of radiology 88 (1051), 20150097, 2015
|Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer|
K Røe, LTG Mikalsen, AJ van der Kogel, J Bussink, H Lyng, AH Ree, ...
Radiation oncology 7 (1), 75, 2012
|An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer|
T Bjørnetrø, KR Redalen, S Meltzer, NS Thusyanthan, R Samiappan, ...
Journal of extracellular vesicles 8 (1), 1567219, 2019
|Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival|
KM Bakke, KH Hole, S Dueland, KK Grøholt, K Flatmark, AH Ree, ...
Acta Oncologica 56 (6), 813-818, 2017
|Circulating exosomal miR-141-3p and miR-375 in metastatic progression of rectal cancer|
S Meltzer, T Bjørnetrø, LG Lyckander, K Flatmark, S Dueland, ...
Translational oncology 12 (8), 1038-1044, 2019
|Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer|
E Kalanxhi, S Meltzer, JV Schou, FO Larsen, S Dueland, K Flatmark, ...
British journal of cancer 118 (10), 1322-1328, 2018
|Dynamic multi‐echo DCE‐ and DSC‐MRI in rectal cancer: Low primary tumor Ktrans and peak are significantly associated with lymph node metastasis|
E Grøvik, KR Redalen, TH Storås, A Negård, SH Holmedal, AH Ree, ...
Journal of Magnetic Resonance Imaging 46 (1), 194-206, 2017
|Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer|
HH Hektoen, K Flatmark, Y Andersson, S Dueland, KR Redalen, AH Ree
BMC cancer 15 (1), 543, 2015
|Learning radiation oncology in Europe: Results of the ESTRO multidisciplinary survey|
JE Bibault, P Franco, GR Borst, W Van Elmpt, D Thorwhart, MP Schmid, ...
Clinical and translational radiation oncology 9, 61-67, 2018